EYP
EyePoint, Inc.
Stock
Stock
Ticker: EYPT
EYPT
Price
Price
CHART BY
Frequently asked questions
What is EyePoint, Inc.'s market capitalization?
The market capitalization of EyePoint, Inc. is $36.91M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for EyePoint, Inc.?
EyePoint, Inc.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$3.744. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for EyePoint, Inc.'s stock?
Currently, 13 analysts cover EyePoint, Inc.'s stock, with a consensus target price of $12.39. Analyst ratings provide insights into the stock's expected performance.
What is EyePoint, Inc.'s revenue over the trailing twelve months?
Over the trailing twelve months, EyePoint, Inc. reported a revenue of $2.79M.
What is the EBITDA for EyePoint, Inc.?
EyePoint, Inc.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$314.38M. EBITDA measures the company's overall financial performance.
What is the free cash flow of EyePoint, Inc.?
EyePoint, Inc. has a free cash flow of -$271.28M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does EyePoint, Inc. have, and what sector and industry does it belong to?
EyePoint, Inc. employs approximately 214 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of EyePoint, Inc.'s shares?
The free float of EyePoint, Inc. is 80.71M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $36.91M
- EPS (TTM)
- -$3.744
- Free Float
- 80.71M
- Revenue (TTM)
- $2.79M
- EBITDA (TTM)
- -$314.38M
- Free Cashflow (TTM)
- -$271.28M
Pricing
- 1D span
- $0.403$0.437
- 52W span
- $0.386$19.00
Analyst Ratings
The price target is $12.39 and the stock is covered by 13 analysts.
Buy
3
Hold
9
Sell
1
Information
EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
- Employees
- 214
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- EYPT
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet